Cargando…
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?
We reviewed similarities and differences of ventilator associated pneumonia in Sars-Cov2 infection and with other ARDS. The differences in epidemiology and outcome will be detailed. Possible explanations of differences in pathophysiology of VAP in Sarscov2 infections will be cited and discussed.
Autores principales: | Wicky, Paul-Henri, Niedermann, Michael S., Timsit, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059113/ https://www.ncbi.nlm.nih.gov/pubmed/33882991 http://dx.doi.org/10.1186/s13054-021-03571-z |
Ejemplares similares
-
What is new in non-ventilated ICU-acquired pneumonia?
por: Saied, Wafa Ibn, et al.
Publicado: (2020) -
After SARS-CoV-2 Pandemics: New Insights into ICU-Acquired Pneumonia
por: Timsit, Jean-Francois
Publicado: (2023) -
Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients
por: Timsit, Jean-François, et al.
Publicado: (2022) -
Update on ventilator-associated pneumonia
por: Timsit, Jean-Francois, et al.
Publicado: (2017) -
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2020)